Stowers researchers announce first genetic model of a human jaw fusion defect known as syngnathia
KANSAS CITY, MO—The face you critiqued in the mirror this morning was sculpted before you were born by a transient population of cells called neural crest cells. Those cells spring from neural tissue of the brain and embryonic spinal cord and travel throughout the body, where they morph into highly specialized bone structures, cartilage, connective tissue, and nerve cells.
Occasionally, neural crest cell development goes awry, causing birth defects affecting regions as diverse as the head, heart or gut. The way these conditions, known collectively as neurocristopathies, manifest themselves depends on the subset of neural crest cells involved: dysfunction in the population moving toward the face, for example, produces defects in the jaw, facial musculature, tongue, teeth, or palate, among others.
Given the importance of neural crest cells throughout the body, biologists have keenly studied the factors that are important for their formation, migration and maturation. Now a paper from the lab of Paul Trainor, Ph.D., Investigator at the Stowers Institute for Medical Research, describes a paradigm in which neural crest cells are formed normally, migrate properly but mature incorrectly. That paper, published in the Dec. 19, 2013, issue of PLOS Genetics, characterizes a mutant mouse that mimics a congenital disorder known as syngnathia in which children are born with fused upper and lower jaws and related facial anomalies.
This finding offers hope for better understanding of syngnathia, which is a relatively rare disease, and other more common craniofacial diseases affecting jaw development. “Almost a third of all birth defects involve the head and face,” says Trainor, noting that most can be blamed on problems relevant to neural crest cells. “Our primary motivation has always been to understand what causes them.”
The jumping off point for the new work was a molecular search the Trainor lab conducted to identify genes required for correct neural crest migration or maturation. One candidate that emerged encoded a protein called Foxc1, which is expressed embryonically in mesodermal and neural crest cell tissues of the head, immediately adjacent to the developing pharynx.
Molecular geneticists typically evaluate what a gene does by eradicating or “knocking out” that gene in an animal and then observing what happens. To test Foxc1 function, Kim Inman, Ph.D., a former postdoctoral fellow in the Trainor lab and the study’s first author, carefully analyzed the miniscule facial bones as well as facial cartilage of newborn Foxc1 “knock-out” mice using red and blue stains that distinguish the two.
“We immediately saw that components of the upper jaw were misshapen and fused to the lower jaw dentary bone,” says Inman, noting that mice also showed abnormal facial muscles and poor formation of the temporomandibular joint, the hinge that allows the jaw to open and close. “When we see defects like this, we immediately suspect neural crest failure.”
The study confirms these suspicions, with a surprising twist. When the team used mouse neural crest cell markers to visualize cells moving toward the embryonic head, they observed fairly normal migration. However, upon arrival at jaw-forming regions neural cells which would normally mature into bone-producing cell, now did so in inappropriate locations.
One interpretation of the new findings is that in normal animals Foxc1, which is a DNA-binding protein, regulates expression of factors that either shape facial soft tissues, block bone construction, or both. In fact, the study builds a substantial case that one downstream signaling factor expressed in the embryonic jaw known as Fgf8 is just such a Foxc1 target. Thus, mice (and presumably humans) carrying a defective Foxc1 gene would display “syngnathic” traits due to loss of these signals.
The Trainor lab also focuses on neurocristopathies caused by impaired cell expansion or migration, such as a more common craniofacial disorder called Treacher Collins Syndrome, in which children exhibit small chins or jaws together with cleft palate, drooping eye slits and ear anomalies leading to hearing loss.
“In a condition like Treacher Collins we see a failure to make enough cells at the beginning of migration, while in syngnathia cells form properly but make bone in an inappropriate place due to loss of Foxc1,” says Trainor. “This means there simply isn’t going to be any one way to address all of these disorders. If you want to prevent or treat them you must understand how each originates cellularly and genetically.”
Inman, now assistant professor of Natural Sciences at Shawnee State University in Portsmouth, Ohio, adds that craniofacial disorders carry a special stigma, one driven home by a sobering summary of over 50 human syngnathia case histories she compiled for the paper. That table lists the extent of jaw fusions and whether patients also showed cleft palate or tongue malformations. Some patients died in infancy, presumably from feeding disorders, while others survived thanks to surgical intervention.
“We need to devise new ways to treat craniofacial defects because of their tremendous medical need,” she says. “But in this condition we are also talking about the face you present to the world. That face determines how you eat, talk, and interact with others. Having facial structures like everyone else is a tremendous part of who you are.”
Other contributors include Tsutomu Kume, Ph.D., of the Feinberg School of Medicine at Northwestern University, who engineered the Foxc1 knock-out mice, and Patricia Purcell, Ph.D., of Boston Children’s Hospital and Harvard Medical School, who provided markers and assessed bone structures in mutant mice.
The study was funded by the National Institute of Dental and Craniofacial Research (RO1 DE 016082), the March of Dimes, and the Stowers Institute for Medical Research.
About the Stowers Institute for Medical Research
The Stowers Institute for Medical Research is a non-profit, basic biomedical research organization dedicated to improving human health by studying the fundamental processes of life. Jim Stowers, founder of American Century Investments, and his wife, Virginia, opened the Institute in 2000. Since then, the Institute has spent over 900 million dollars in pursuit of its mission.
Currently, the Institute is home to nearly 550 researchers and support personnel; over 20 independent research programs; and more than a dozen technology-development and core facilities.